Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 199-203

  Burrel, Sonia ^a,b   Aït Arkoub, Zaïna ^b   Agut, Henri ^a,b   Boutolleau, David ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiviral resistance; Herpes simplex virus; Natural polymorphism; UL30 DNA polymerase; UL42 processivity factor

Indexed keywords

DNA POLYMERASE; UL42 PROCESSIVITY FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ARTICLE; CELL NUCLEUS; DNA POLYMORPHISM; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HYDROGEN BOND; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; EXODEOXYRIBONUCLEASES; GENOTYPE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; SIMPLEXVIRUS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84355161562     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.10.016     Document Type: Article

References (17)

1. Alvisi G., Avanzi S., Musiani D., Camozzi D., Leoni V., Ly-Huynh J.D., Ripalti A. Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal. Biochemistry 2008, 47:13764-13777.
2. Bonnafous P., Verbelen M., Petrella S., Deback C., Gautheret-Dejean A., Boutolleau D., Naesens L., Agut H. Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development. Antiviral Res. 2010, 86:316-319.
3. Boutolleau D., Deback C., Bressollette-Bodin C., Conan F., Ait-Arkoub Z., Imbert-Marcille B.M., Agut H. Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor. Antivir. Ther. 2009, 14:847-852.
4. Burrel S., Deback C., Agut H., Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob. Agents Chemother. 2010, 54:4833-4842.
5. Chiba A., Suzutani T., Saijo M., Koyano S., Azuma M. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol. 1998, 42:401-407.
6. Dignani M.C., Mykietiuk A., Michelet M., Intile D., Mammana L., Desmery P., Milone G., Pavlovsky S. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation. Bone Marrow Transplant. 2002, 29:263-267.
7. Englund J.A., Zimmerman M.E., Swierkosz E.M., Goodman J.L., Scholl D.R., Balfour H.H. Herpes simplex virus resistant to acyclovir :A study in a tertiary care center. Ann. Intern. Med. 1990, 112:416-422.
8. Gao M., DiTusa S.F., Cordingley M.G. The C-terminal third of UL42, a HSV-1 DNA replication protein, is dispensable for viral growth. Virology 1993, 194:647-653.
9. Gilbert C., Bestman-Smith J., Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist. Update. 2002, 5:88-114.
10. Hill E.L., Hunter G.A., Ellis M.N. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 1991, 35:2322-2328.
11. Komazin-Meredith G., Santos W.L., Filman D.J., Hogle J.M., Verdine G.L., Coen D.M. The positively charged surface of herpes simplex virus UL42 mediates DNA binding. J. Biol. Chem. 2008, 283:6154-6161.
12. Loregian A., Palu G. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy. Clin. Microbiol. Infect. 2005, 11:437-446.
13. Loregian A., Piaia E., Cancellotti E., Papini E., Marsden H.S., Palu G. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology 2000, 273:139-148.
14. McGeoch D.J., Dolan A., Donald S., Rixon F.J. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 1985, 181:1-13.
15. McGeoch D.J., Moss H.W., McNab D., Frame M.C. DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 1987, 68:19-38.
16. Randell J.C., Komazin G., Jiang C., Hwang C.B., Coen D.M. Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis. J. Virol. 2005, 79:12025-12034.
17. Zuccola H.J., Filman D.J., Coen D.M., Hogle J.M. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol. Cell 2000, 5:267-278.